TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07139743: Obe-cel in Refractory Progressive Forms of Multiple Sclerosis

Sponsor: Autolus Limited · Phase: PHASE1 · Area: CNS_NEUROLOGY · Target Enrollment: 24 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$870,672

Rescue Site Savings

+$580,448

Unlock Full NCT07139743 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07139743 Rescue Dossier →